Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
West Palm Beach, FL
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Columbus, GA
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Columbus, GA
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Evansville, IN
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Renton, WA
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Renton, WA
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Hazelwood, MO
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Hazelwood, MO
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Winston-Salem, NC
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Warwick, RI
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Dallas, TX
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Houston, TX
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
San Antonio, TX
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Virginia Beach, VA
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Mount Pleasant, SC
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients
A Phase 1 Open-label Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients With Magnetic Resonance Imaging Evidence of Leptomeningeal Enhancement
Status: Enrolling
Updated:  8/29/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients
A Phase 1 Open-label Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients With Magnetic Resonance Imaging Evidence of Leptomeningeal Enhancement
Status: Enrolling
Updated: 8/29/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Quantitation of McArdle's Sign and Evaluation of Specificity for Multiple Sclerosis
Quantitation of McArdle's Sign and Evaluation of Specificity for Multiple Sclerosis
Status: Enrolling
Updated:  8/29/2017
The Mayo Clinic
mi
from
Rochester, MN
Quantitation of McArdle's Sign and Evaluation of Specificity for Multiple Sclerosis
Quantitation of McArdle's Sign and Evaluation of Specificity for Multiple Sclerosis
Status: Enrolling
Updated: 8/29/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Phonomotor Treatment of Word Retrieval Deficits in Individuals With Aphasia
Real Word Effects in Phonological Treatment for Word Retrieval
Status: Enrolling
Updated:  8/30/2017
VA Puget Sound Health Care System Seattle Division, Seattle, WA
mi
from
Seattle, WA
Phonomotor Treatment of Word Retrieval Deficits in Individuals With Aphasia
Real Word Effects in Phonological Treatment for Word Retrieval
Status: Enrolling
Updated: 8/30/2017
VA Puget Sound Health Care System Seattle Division, Seattle, WA
mi
from
Seattle, WA
Click here to add this to my saved trials
Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion
Physiological Effects of Intrathoracic Pressure Regulation in Patients With Decreased Cerebral Perfusion Due to Brain Injury or Intracranial Pathology
Status: Enrolling
Updated:  8/30/2017
Denver
mi
from
Denver, CO
Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion
Physiological Effects of Intrathoracic Pressure Regulation in Patients With Decreased Cerebral Perfusion Due to Brain Injury or Intracranial Pathology
Status: Enrolling
Updated: 8/30/2017
Denver
mi
from
Denver, CO
Click here to add this to my saved trials
Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion
Physiological Effects of Intrathoracic Pressure Regulation in Patients With Decreased Cerebral Perfusion Due to Brain Injury or Intracranial Pathology
Status: Enrolling
Updated:  8/30/2017
Investigational Site - Baltimore
mi
from
Baltimore, MD
Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion
Physiological Effects of Intrathoracic Pressure Regulation in Patients With Decreased Cerebral Perfusion Due to Brain Injury or Intracranial Pathology
Status: Enrolling
Updated: 8/30/2017
Investigational Site - Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS
MR Imaging of Inflammatory Responses in the Central Nervous System With Ferumoxytol-Enhanced MRI
Status: Enrolling
Updated:  8/30/2017
Stanford University Hospitals and Clinics
mi
from
Stanford, CA
Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS
MR Imaging of Inflammatory Responses in the Central Nervous System With Ferumoxytol-Enhanced MRI
Status: Enrolling
Updated: 8/30/2017
Stanford University Hospitals and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
Prevention of Alcohol Intolerance
Status: Enrolling
Updated:  8/31/2017
Johns Hopkins University
mi
from
Baltimore, MD
Prevention of Alcohol Intolerance
Status: Enrolling
Updated: 8/31/2017
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis
An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Intravenously Into Patients With Multiple Sclerosis
Status: Enrolling
Updated:  8/31/2017
Ageless Regenerative Institute LLC
mi
from
Aventura, FL
Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Into Patients With Multiple Sclerosis
An Open-label, Non-Randomized, Multi-Center Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered Intravenously Into Patients With Multiple Sclerosis
Status: Enrolling
Updated: 8/31/2017
Ageless Regenerative Institute LLC
mi
from
Aventura, FL
Click here to add this to my saved trials
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated:  8/31/2017
University of Arizona
mi
from
Tucson, AZ
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated: 8/31/2017
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated:  8/31/2017
University of Southern California
mi
from
Los Angeles, CA
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated: 8/31/2017
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated:  8/31/2017
Georgetown University
mi
from
Washington, D.C.,
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated: 8/31/2017
Georgetown University
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated:  8/31/2017
University of Miami - Biorepository
mi
from
Miami, FL
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated: 8/31/2017
University of Miami - Biorepository
mi
from
Miami, FL
Click here to add this to my saved trials
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated:  8/31/2017
University of Miami
mi
from
Miami, FL
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated: 8/31/2017
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated:  8/31/2017
Emory University
mi
from
Atlanta, GA
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated: 8/31/2017
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated:  8/31/2017
Univ of Illinois
mi
from
Chicago, IL
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated: 8/31/2017
Univ of Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated:  8/31/2017
University of Maryland
mi
from
Baltimore, MD
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated: 8/31/2017
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated:  8/31/2017
Massachusetts General Hospital
mi
from
Boston, MA
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated: 8/31/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated:  8/31/2017
University of New Mexico
mi
from
Albuquerque, NM
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated: 8/31/2017
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated:  8/31/2017
Columbia University
mi
from
New York, NY
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated: 8/31/2017
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated:  8/31/2017
Wake Forest University
mi
from
Winston-Salem, NC
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated: 8/31/2017
Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated:  8/31/2017
UT Southwestern Medical Center
mi
from
Dallas, TX
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated: 8/31/2017
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated:  8/31/2017
University of Texas Medical School in Houston
mi
from
Houston, TX
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated: 8/31/2017
University of Texas Medical School in Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated:  8/31/2017
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH)
Status: Enrolling
Updated: 8/31/2017
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo
Comparison of Anastrozole and Testosterone Versus Placebo and Testosterone Treatment of Reproductive and Sexual Dysfunction in Men With Epilepsy and Hypogonadism
Status: Enrolling
Updated:  8/31/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo
Comparison of Anastrozole and Testosterone Versus Placebo and Testosterone Treatment of Reproductive and Sexual Dysfunction in Men With Epilepsy and Hypogonadism
Status: Enrolling
Updated: 8/31/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  9/5/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  9/5/2017
Cockerham Eye Consultant
mi
from
Los Altos, CA
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Cockerham Eye Consultant
mi
from
Los Altos, CA
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  9/5/2017
Precision Eye Care
mi
from
National City, CA
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Precision Eye Care
mi
from
National City, CA
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  9/5/2017
North Bay Eye Associates
mi
from
Petaluma, CA
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
North Bay Eye Associates
mi
from
Petaluma, CA
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  9/5/2017
Russell P Edwards M.D.
mi
from
San Diego, CA
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Russell P Edwards M.D.
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  9/5/2017
Pacific Eye Associates
mi
from
San Francisco, CA
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Pacific Eye Associates
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  9/5/2017
Eye Surgical and Medical Associates
mi
from
Visalia, CA
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Eye Surgical and Medical Associates
mi
from
Visalia, CA
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  9/5/2017
The Eye Care Group
mi
from
New Haven, CT
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
The Eye Care Group
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  9/5/2017
Avail Clinical Research
mi
from
DeLand, FL
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Avail Clinical Research
mi
from
DeLand, FL
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  9/5/2017
University of Florida Gainesville
mi
from
Gainesville, FL
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
University of Florida Gainesville
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  9/5/2017
Florida Retina Consultants
mi
from
Lakeland, FL
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Florida Retina Consultants
mi
from
Lakeland, FL
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  9/5/2017
University of Miami School of Medicine
mi
from
Miami, FL
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
University of Miami School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated:  9/5/2017
Sarasota Retina Institute
mi
from
Sarasota, FL
A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
A Prospective Case-crossover Study to Evaluate the Possible Association Between the Use of PDE5 Inhibitors and the Risk of Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
Status: Enrolling
Updated: 9/5/2017
Sarasota Retina Institute
mi
from
Sarasota, FL
Click here to add this to my saved trials